Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Transplant
Open-data reference.
16 US clinical trials · 13 currently recruiting
Active & Recent Trials
US National TOP Registry
TransMedics
NCT06513091
Thoracic Specimen Registry
Mayo Clinic
NCT04118660
Tocilizumab in Lung Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06033196
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
XVIVO Perfusion
NCT05101460
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06476132
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates
Mayo Clinic
NCT05426200
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
Mayo Clinic
NCT05547698
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Northwestern University
NCT05671887
TEE and Dysphagia in Lung Transplantation
University of California, Los Angeles
NCT06089434
Planned Semi-Elective Lung Tx Study
University of Florida
NCT04601818
A Study of Latin Dance for Post- Lung Transplant
Mayo Clinic
NCT05924113
The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
University of Florida
NCT03886961
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
Mayo Clinic
NCT06770023
10°C vs 4°C Lung Preservation RCT
University Health Network, Toronto
NCT05898776
Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease
University of Maryland, Baltimore
NCT03562728
Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0
Duke University
NCT03226431
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 2 |
| Phase 2 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Lung Transplant Trial Landscape
ClinicalTrials.gov lists 16 US studies indexed under Lung Transplant, and 13 of those are currently open to recruitment — roughly 81% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Lung Transplant shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 4 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Lung Transplant is led by Mayo Clinic with 5 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 16 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Lung Transplant?
PlainTrial tracks 16 US clinical trials for Lung Transplant, of which 13 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Lung Transplant?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.